Marcin KOWANETZ
6Patents
1h-index
20Co-inventors
43Inventor score
Filing activity: Sep 10, 2015 → May 11, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11300570B2 | Therapeutic and diagnostic methods for cancer | Emerging Cross-Sectional Technologies | 2 | Active |
| US11254987B2 | PD-L1 promoter methylation in cancer | Chemistry; Metallurgy | 1 | Active |
| US10689445B2 | Anti-PD-L1 antibodies and diagnostic uses thereof | Physics | 1 | Active |
| US11530269B2 | Anti-PD-L1 antibodies and diagnostic uses thereof | Physics | 0 | Active |
| US11535671B2 | Therapeutic and diagnostic methods for cancer | Physics | 0 | Active |
| US11299544B2 | Biomarkers and methods of treating PD-1 and PD-L1 related conditions | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.